This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arrick, B A
Right arrow Articles by Griffin, L A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arrick, B A
Right arrow Articles by Griffin, L A

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 January; 14(1): 619-628

Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells.

B A Arrick, R L Grendell and L A Griffin

Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire 03755.

ABSTRACT

The mRNA for transforming growth factor beta 3 (TGF-beta 3) includes a long (1.1-kb) 5' noncoding region which exerts a potent inhibitory effect on translational efficiency. We now report that many human breast cancer cell lines (T47-D, SK-BR-3, ZR-75-1, and BT-474) express two mRNA species for TGF-beta 3: the 3.5-kb transcript previously described as the only TGF-beta 3 mRNA species in cells and a novel 2.6-kb transcript which lacks approximately 870 nucleotides from the 5' noncoding region. The 5' end of the shorter transcript was sequenced, establishing it to be a 5' truncation of the full-length TGF-beta 3 transcript. Estradiol decreased mRNA levels of both TGF-beta 3 mRNA transcripts to an equivalent degree in estrogen receptor-positive cells. In contrast, the synthetic progestin gestodene altered the relative abundance of the two transcripts, preferentially diminishing the expression of the 2.6-kb transcript. The potential for enhanced mRNA translation attributable to the shorter 5' noncoding region was evaluated by transfection of cells with chimeric plasmid constructs in which the transcription unit consisted of coding sequence for chloramphenicol acetyltransferase downstream of the 5' noncoding sequence from TGF-beta 3. The translational efficiency of chloramphenicol acetyltransferase-encoding mRNA containing the shorter 5' noncoding region of the 2.6-kb TGF-beta 3 transcript was approximately seven times greater than with the full-length 5' noncoding region of TGF-beta 3. Polysome analysis of TGF-beta 3 mRNA in SK-BR-3 cells supported the hypothesis that the 2.6-kb transcript was more actively engaged in translation.

Mol Cell Biol. 1994 January; 14(1): 619-628




This article has been cited by other articles:

  • Astanehe, A., Arenillas, D., Wasserman, W. W., Leung, P. C. K., Dunn, S. E., Davies, B. R., Mills, G. B., Auersperg, N. (2008). Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer. J. Cell Sci. 121: 664-674 [Abstract] [Full Text]  
  • Laping, N. J., Everitt, J. I., Frazier, K. S., Burgert, M., Portis, M. J., Cadacio, C., Gold, L. I., Walker, C. L. (2007). Tumor-Specific Efficacy of Transforming Growth Factor-{beta}RI Inhibition in Eker Rats. Clin. Cancer Res. 13: 3087-3099 [Abstract] [Full Text]  
  • Meric, F., Hunt, K. K. (2002). Translation Initiation in Cancer: A Novel Target for Therapy. Molecular Cancer Therapeutics 1: 971-979 [Abstract] [Full Text]  
  • Fraser, D., Wakefield, L., Phillips, A. (2002). Independent Regulation of Transforming Growth Factor-{beta}1 Transcription and Translation by Glucose and Platelet-Derived Growth Factor. Am. J. Pathol. 161: 1039-1049 [Abstract] [Full Text]  
  • Cazzola, M., Skoda, R. C. (2000). Translational pathophysiology: a novel molecular mechanism of human disease. Blood 95: 3280-3288 [Abstract] [Full Text]  
  • Archey, W. B., Sweet, M. P., Alig, G. C., Arrick, B. A. (1999). Methylation of CpGs as a Determinant of Transcriptional Activation at Alternative Promoters for Transforming Growth Factor-{beta}3. Cancer Res. 59: 2292-2296 [Abstract] [Full Text]  
  • Morgan, R, Sargent, M. (1997). The role in neural patterning of translation initiation factor eIF4AII; induction of neural fold genes. Development 124: 2751-2760 [Abstract]  
  • Bernstein, J., Shefler, I., Elroy-Stein, O. (1995). The Translational Repression Mediated by the Platelet-derived Growth Factor 2/c- sis mRNA Leader Is Relieved during Megakaryocytic Differentiation. J. Biol. Chem. 270: 10559-10565 [Abstract] [Full Text]  
  • Davuluri, R. V., Suzuki, Y., Sugano, S., Zhang, M. Q. (2000). CART Classification of Human 5' UTR Sequences. Genome Res 10: 1807-1816 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»